H.R. 3029 · 119th Congress · Science, technology, communications
To Amend the Research and Development, Competition, and Innovation Act to Support Nucleic Acid Screening, and for Other Purposes.
How the House voted
Yea from the left, nay from the right, each side by party
House · Jul 20, 2026
Passed by voice vote.
Passed the House on July 20, 2026.
Latest action: Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation
- IntroducedApr 28, 2025
- CommitteeJul 16, 2026
- Passed HouseJul 20, 2026
- Passed Senate
- Became law
On the record
- Cosponsors
- 3
- 2 Democrats, 1 Republican
- Committees
- Senate Committee on Commerce, Science, and TransportationHouse Committee on Science, Space, and Technology
- Lobbying
- At least 1
- organization named it2025 Q2
What it does
This bill directs the National Institute of Standards and Technology to carry out measurement research supporting best practices and technical standards for biosecurity measures tied to nucleic acid synthesis, including testing to improve the accuracy and reliability of screening and methods for managing sequence-of-concern databases.
This bill directs the National Institute of Standards and Technology to carry out measurement research supporting best practices and technical standards for biosecurity measures tied to nucleic acid synthesis, including testing to improve the accuracy and reliability of screening and methods for managing sequence-of-concern databases. It requires the Director to convene a consortium of industry, universities, nonprofits, and customers to set consensus priorities and best practices for synthetic nucleic acid procurement screening. The Director must report the consortium's findings to the Senate Commerce and House Science committees within 18 months of the consortium's first meeting. It also authorizes $5,000,000 for each of fiscal years 2027 through 2031 to carry out this work, and adds risk management for engineering biology and biomanufacturing, including artificial intelligence risks, to an existing NIST standards list.
Each stop is a step the bill’s own record states, with the date it happened. A ring is a step not yet taken. A bill becomes law when the President signs it or Congress overrides a veto.
At least 1 organization named this measure in a lobbying filing. A floor, not a total: they were counted by the client name on 1 quarterly report filed by 1 lobbying firm in 2025 Q2. An organization that lobbied this measure without naming it is not counted here.
The filings record that lobbying was reported on the measure. The form has no per-bill dollar figure and no field for a position, so nothing here says how much was spent or which side an organization took.
From the LD-2 quarterly lobbying filings published at lda.gov by the Senate Office of Public Records. Read for 2025 Q1, 2025 Q2, 2025 Q3, 2025 Q4, 2026 Q1, 2026 Q2 and 2026 Q3. Our copy holds 24 fewer filings for 2025 Q1, 39 fewer filings for 2025 Q2, 42 fewer filings for 2025 Q3, 33 fewer filings for 2025 Q4, 28 fewer filings for 2026 Q1, 48 fewer filings for 2026 Q2 and 218 fewer filings for 2026 Q3 than the Senate's register counts, so those quarters are the filings we could read rather than every one filed. 2026 Q4 is still inside its filing window, so that quarter is only the filings posted so far.
Congress.gov bill status and cosponsor records; the House Clerk and Senate roll calls; lobbying reports filed under the Lobbying Disclosure Act (lda.gov); the plain summary and provisions are read from the bill text, each with its section.